Format

Send to

Choose Destination
AORN J. 2010 May;91(5):599-606; quiz 607-9. doi: 10.1016/j.aorn.2009.11.065.

Methicillin-resistant Staphylococcus aureus: an update.

Author information

1
Department of Surgery at University, Hospital Lewisham, London, England.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a serious threat to patients in health care facilities and the community. A MRSA infection can be much more severe than other bacterial infections and can be life-threatening. Resistance to common antibiotics makes treating MRSA costly and difficult. Prolonged hospitalization requiring specialized IV antibiotics also has cost implications. Treatment of MRSA can include use of antibiotics; topical therapies such as honey, topical silver, and gentian violet; and bacteriophages. Research is being conducted on new antibiotics and a MRSA vaccine.

PMID:
20451002
DOI:
10.1016/j.aorn.2009.11.065
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center